BASTA JAMES — SEC Form 4 filings
SEC reporting owner CIK 1792726. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-01-05 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 27,356 shares, $409,601 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 3,805 shares @ $29.46 ($112,095) in Intellia Therapeutics, Inc., filed 2024-01-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Intellia Therapeutics, Inc. (NTLA) | EVP, General Counsel | 6 | — | 6 legs · 27,356 sh · $409,601 | 6 |
Form 4 filings — BASTA JAMES
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-03 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 46,080 @ $0 · Sale (S): 1,211 @ $13.78 · Grant/award (A): 65,829 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Intellia Therapeutics, Inc. (NTLA) | Sale (S): 10,397 @ $9.21 | EDGAR |
| 2025-03-04 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 40,000 @ $0 · Sale (S): 2,572 @ $8.99 · Grant/award (A): 57,143 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Intellia Therapeutics, Inc. (NTLA) | Sale (S): 7,074 @ $12.18 | EDGAR |
| 2024-03-05 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 32,394 @ $0 · Sale (S): 2,297 @ $32.99 · Grant/award (A): 46,752 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Intellia Therapeutics, Inc. (NTLA) | Sale (S): 3,805 @ $29.46 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-04 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1792726 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →